Gemome Sequence Map

Big Data and Clinical Genomics

Progress Is Being Made Toward Using Big Data for Genomics-Guided Precision Medicine Precision medicine springs from a paradox. On the one hand, researchers in the...

AI Finds Mutations in “Junk” DNA that Cause Autism

A team of Princeton University-led researchers has used an artificial intelligence algorithm to identify mutations in “junk” DNA that can cause autism. The findings,...

Flatiron Health, Foundation Medicine Publish Study Validating Clinico-Genomic Database

The study validates that real-world data obtained from routine clinical care to create a multi-institution clinico-genomic database can yield clinically meaningful insights.

DNAnexus, UPMC, Sutter Health Launch Clinico-Genomic MS Precision Medicine Study

Clinico-genomic research study aims to improve personalized treatments for people with multiple sclerosis

Rady Researchers Use AI ‘Pipeline’ for Rapid Diagnosis of Rare Genetic Diseases

Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) have built an automated pipeline designed to deliver a potential diagnosis in record time for hospitalized...
Abstract DNA.

Panel Identifies Hurdles to Wider AI Use in Diagnostic, Rx Development

Artificial intelligence (AI) is gaining a foothold in the discovery and development of drugs and diagnostics—but its use in both will remain limited unless companies surmount hurdles to the technology in the next few years, a panel of industry executives agreed.

Clinical Trials Data Partnership Joins Verily with Pharma Giants

Verily Life Sciences, the healthcare subsidiary of Google parent Alphabet, said today it will partner with four pharma giants—Novartis, Otsuka Pharmaceutical, Pfizer, and Sanofi—to...

Tempus Attracts $200M in Series F Financing, Bringing Total Raised to $510M

Tempus, a precision medicine technology company focused on collecting and analyzing molecular and clinical data, has raised $200 million in Series F financing, bringing...

Lack of Diverse Ancestry Data Hinders Polygenic Risk Scores

A new study shows PRSs developed by studying Europeans do a better job at predicting disease risk for people of European ancestry than for those of other ancestries
Scroll Up